Pharmaceutical agents and therapeutic privileges
Pharmaceutical agents and therapeutic privileges
This domain tests the statutory and regulatory limits on Kansas optometric prescribing. A Kansas license alone does not authorize every drug; the optometrist must hold the therapeutic authority recognized by the Board and stay within the Act.
Core rules
- Kansas optometrists may use diagnostic pharmaceutical agents and, within the authorized therapeutic scope, topical and oral agents for ocular conditions. The Board's rules define certification, education, and practice limits.
- Prescribing requires a patient-specific evaluation, documented indication, dose, duration, allergies, and follow-up. Standing orders and prescribing for oneself or family outside a documented patient relationship are high-risk.
- Controlled substances require compliance with federal DEA rules and Kansas prescriber obligations, including the Kansas prescription monitoring program, K-TRACS, where applicable.
- Surgical and laser procedures remain outside optometric scope; drugs do not convert a surgical procedure into optometric care.
- Samples must be logged and labeled; dispensing without records creates both board and pharmacy-law exposure.
Worked example
An optometrist diagnoses bacterial conjunctivitis and prescribes topical moxifloxacin. The record should show the examination, the diagnosis, the drug, strength, dosing, duration, allergy review, and return precautions. If the patient also has severe pain and decreased vision, the optometrist should reconsider the diagnosis and refer rather than simply adding an oral antibiotic. The privilege is for treating ocular disease, not for prescribing outside the documented findings.
Traps
Assuming all topical drugs are diagnostic; prescribing without a record; ignoring K-TRACS; using a sample as a substitute for documentation; exceeding the Board's therapeutic certification.